Literature DB >> 24939302

Involvement of VKORC1 in the inhibition of calcium oxalate crystal formation in HK-2 cells.

Bo Hu1, Hao-Ran Wu1, Zhi-Yong Ma2, Zhuan-Chang Wu2, Ying-Mei Lu2, Guo-Wei Shi3.   

Abstract

The vitamin K epoxide reductase complex subunit 1 (VKORC1), the rate-limiting enzyme for vitamin K recycling, is significantly down-regulated in the kidneys of urolithiasis patients. This study searched for direct evidence to define the inhibitory activity of VKORC1 against calcium oxalate (CaOx) crystal formation. In the experiment of VKORC1 overexpression, HK-2 cells were transfected with the pFLAG-CMV-7.1-VKORC1 plasmid as a pFLAG-CMV-7.1-VKORC1 transfection group or the pFLAG-CMV-7.1 plasmid as a pFLAG-CMV-7.1 control group. In the experiment of VKORC1 knockdown, HK-2 cells were transfected with the PGPU6/GFP/Neo-VKORC1shRNA-2 as a PGPU6/GFP/Neo-VKORC1shRNA-2 transfection group or the PGPU6/GFP/Neo-shRNA-NC plasmid as a PGPU6/GFP/Neo-shRNA-NC control group. The expression of VKORC1 in HK-2 cells was detected by real-time quantitative PCR and Western blotting. The CaOx crystal formation was observed under the laser-scanning confocal microscope. It was found that the expression levels of VKORC1 mRNA and protein were significantly higher in the pFLAG-CMV-7.1-VKORC1 transfection group than in the pFLAG-CMV-7.1 control group (P<0.01). The number of CaOx crystals in HK-2 cells incubated in fluorescently labeled CaOx monohydrate (COM) crystal medium for 48 h was 14±4 per field (100×) in the pFLAG-CMV-7.1-VKORC1 transfection group and 26±5 per field (100×) in the pFLAG-CMV-7.1 control group respectively under the laser-scanning confocal microscope. The amount of CaOx crystal aggregation and formation in the pFLAG-CMV-7.1-VKORC1 transfection group was significantly reduced as compared with the pFLAG-CMV-7.1 control group (P<0.05). The expression levels of VKORC1 mRNA and protein were significantly lower in the PGPU6/GFP/Neo-VKORC1shRNA-2 transfection group than in the PGPU6/GFP/Neo-shRNA-NC control group (P<0.05). The number of CaOx crystals in HK-2 cells incubated in fluorescently labeled COM crystal medium was 65±11 per field (100×) in the PGPU6/GFP/Neo-VKORC1shRNA-2 transfection group and 24±6 per field (100×) in the PGPU6/GFP/Neo-shRNA-NC control group respectively under the laser-scanning confocal microscope. The amount of CaOx crystal aggregation and formation in the PGPU6/GFP/Neo-VKORC1shRNA-2 transfection group was significantly increased as compared with the PGPU6/GFP/Neo-shRNA-NC control group (P<0.05). These findings suggested that the VKORC1 protein could inhibit CaOx salt crystallization, adhesion and aggregation. This research would help us to understand the mechanisms involving the interaction between crystallization and epithelial cells and the formation of CaOx.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939302     DOI: 10.1007/s11596-014-1286-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

Review 1.  Kidney stones.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2004-06-12

Review 2.  Inhibitors of stone formation.

Authors:  E M Worcester
Journal:  Semin Nephrol       Date:  1996-09       Impact factor: 5.299

3.  Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells.

Authors:  S R Khan; K J Byer; S Thamilselvan; R L Hackett; W T McCormack; N A Benson; K L Vaughn; G W Erdos
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

4.  Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.

Authors:  Phulwinder K Grover; Rosemary L Ryall
Journal:  Clin Sci (Lond)       Date:  2002-04       Impact factor: 6.124

5.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

Review 6.  Kidney stones: pathophysiology and medical management.

Authors:  Orson W Moe
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

7.  Decreased expression of vitamin K epoxide reductase complex subunit 1 in kidney of patients with calcium oxalate urolithiasis.

Authors:  Bo Hu; Tao Wang; Zhuo Liu; Xiaolin Guo; Jun Yang; Jihong Liu; Shaogang Wang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

8.  Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.

Authors:  A M Stapleton; R L Ryall
Journal:  Br J Urol       Date:  1995-06

9.  Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization.

Authors:  S N Pillay; J R Asplin; F L Coe
Journal:  Am J Physiol       Date:  1998-08

10.  Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.

Authors:  F Atmani; S R Khan
Journal:  Urol Res       Date:  1995
View more
  1 in total

1.  The effects of HAP and macrophage cells to the expression of inflammatory factors and apoptosis in HK-2 cells of vitro co-cultured system.

Authors:  Junchuan Yu; Yaoliang Deng; Zhiwei Tao; Weixia Liang; Xiaofeng Guan; Jihua Wu; Xin Ning; Yunlong Liu; Quan Liu; Ziqi He
Journal:  Urolithiasis       Date:  2017-12-13       Impact factor: 3.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.